§ 13F · FUND PROFILE
Frazier Life Sciences Management, L.P..
AUM · $4.6B (13F)Positions · 41Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$198M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | 7.68M | $899M | 19.6% | ±0% |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 18.09M | $613M | 13.3% | +7% |
| 3 | ERAS | ERASCA INC | 24.98M | $458M | 10.0% | +1% |
| 4 | MBX | MBX BIOSCIENCES INC | 6.65M | $367M | 8.0% | ±0% |
| 5 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9.87M | $259M | 5.6% | ±0% |
| 6 | TRVI | TREVI THERAPEUTICS INC | 9.94M | $185M | 4.0% | ±0% |
| 7 | KRYS | KRYSTAL BIOTECH INC | 481K | $179M | 3.9% | ±0% |
| 8 | MAZE | MAZE THERAPEUTICS INC | 5.03M | $150M | 3.3% | +10% |
| 9 | PHAT | PHATHOM PHARMACEUTICALS INC | 12.47M | $135M | 2.9% | ±0% |
| 10 | PVLA | PALVELLA THERAPEUTICS INC NE | 882K | $135M | 2.9% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FRAZIER SIGNAL
AC read
Frazier Life Sciences Management, L.P. is a Other fund managing $4.6 billion in assets. The fund runs a portfolio of 41 positions.
Read the full dossier →